Roivant Sciences (ROIV) Reiterated at Overweight by Cantor Fitzgerald After AAD Presentation
March 30, 2026 9:21 AM
Cantor Fitzgerald analyst Prakhar Agrawal reiterated an Overweight rating on Roivant Sciences (NASDAQ: ROIV).The analyst commented, "At AAD, we also ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
